ATE330969T1 - Impfstoffe basierend auf mutanten des virus der infektiösen bursal-krankheit - Google Patents

Impfstoffe basierend auf mutanten des virus der infektiösen bursal-krankheit

Info

Publication number
ATE330969T1
ATE330969T1 AT01202532T AT01202532T ATE330969T1 AT E330969 T1 ATE330969 T1 AT E330969T1 AT 01202532 T AT01202532 T AT 01202532T AT 01202532 T AT01202532 T AT 01202532T AT E330969 T1 ATE330969 T1 AT E330969T1
Authority
AT
Austria
Prior art keywords
mutants
disease virus
bursal disease
infectious bursal
vaccines based
Prior art date
Application number
AT01202532T
Other languages
English (en)
Inventor
Adriaan Antonius Wilhelmu Loon
Egbert Mundt
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE330969T1 publication Critical patent/ATE330969T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01202532T 2000-07-07 2001-07-02 Impfstoffe basierend auf mutanten des virus der infektiösen bursal-krankheit ATE330969T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202430 2000-07-07
EP01201064 2001-03-22

Publications (1)

Publication Number Publication Date
ATE330969T1 true ATE330969T1 (de) 2006-07-15

Family

ID=26072471

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01202532T ATE330969T1 (de) 2000-07-07 2001-07-02 Impfstoffe basierend auf mutanten des virus der infektiösen bursal-krankheit

Country Status (13)

Country Link
US (1) US6485940B2 (de)
JP (1) JP2002095485A (de)
KR (1) KR100759769B1 (de)
CN (1) CN1257973C (de)
AT (1) ATE330969T1 (de)
AU (1) AU780878B2 (de)
BR (1) BR0102776A (de)
CA (1) CA2351010C (de)
DE (1) DE60120840T2 (de)
HU (1) HU225488B1 (de)
MX (1) MXPA01006919A (de)
NZ (1) NZ512800A (de)
PL (1) PL199159B1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1908822B1 (de) * 2003-03-24 2010-10-13 Intervet International B.V. Infektiöse Bursitis-Virus Mutanten und Impfstoffe
US7491399B2 (en) * 2005-06-23 2009-02-17 University Of Maryland Biotechnology Institute In Ovo vaccine against infectious bursal disease
CN100384990C (zh) * 2005-11-14 2008-04-30 浙江大学 传染性法氏囊病病毒无毒力毒株构建方法
DE102006054260A1 (de) * 2006-02-28 2007-09-27 Lohmann Animal Health Gmbh & Co. Kg Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05501064A (ja) 1990-05-04 1993-03-04 ユニバーシティ　オブ　メリーランド　アット　カレッジ　パーク Ｉｂｄｖタンパク質に関連する特異的ｄｎａ配列並びにベクター、宿主およびワクチン
US5788970A (en) 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
CA2238659C (en) * 1997-05-26 2010-12-14 Akzo Nobel N.V. Recombinant birnavirus vaccine
WO2000012677A2 (en) 1998-09-01 2000-03-09 The University Of Hong Kong Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines

Also Published As

Publication number Publication date
CA2351010C (en) 2010-12-14
KR20020013387A (ko) 2002-02-20
HU225488B1 (en) 2006-12-28
CN1366041A (zh) 2002-08-28
HU0102823D0 (en) 2001-09-28
KR100759769B1 (ko) 2007-10-04
CN1257973C (zh) 2006-05-31
MXPA01006919A (es) 2003-09-25
CA2351010A1 (en) 2002-01-07
HUP0102823A2 (hu) 2002-04-29
DE60120840D1 (de) 2006-08-03
AU5419601A (en) 2002-01-10
BR0102776A (pt) 2002-07-23
DE60120840T2 (de) 2006-11-16
PL199159B1 (pl) 2008-08-29
NZ512800A (en) 2002-03-01
US6485940B2 (en) 2002-11-26
AU780878B2 (en) 2005-04-21
JP2002095485A (ja) 2002-04-02
PL348550A1 (en) 2002-01-14
HUP0102823A3 (en) 2005-06-28
US20020064532A1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
DK1618889T3 (da) Influenzavaccine
MXPA05009580A (es) Vacuna contra el virus de la influenza.
HRP20040195B1 (hr) Cjepivo protiv bolesti zapadnoga nila
EP1504112A4 (de) Entwicklung einer vakzine zur prävention von infektionen mit dem filovirus bei primaten
PT777490E (pt) Enterotoxina mutante eficaz como adjuvante oral nao toxico
JP2004509903A5 (de)
ATE272410T1 (de) Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
EA200900784A1 (ru) Вакцины, включающие антиген из четырех штаммов вируса гриппа
DK1383795T3 (da) Rekombinant nucleoproteinmutant fra Newcastle disease-virus som markörvaccine
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
MX2022000718A (es) Vacuna en vector recombinante de adenovirus aviar serotipo 9.
JP2006512078A5 (de)
ATE416788T1 (de) Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
EP1395283A4 (de) Heterologer schutz, induziert durch immunisierung mit der invaplex-vakzine
DE60120840D1 (de) Impfstoffe basierend auf Mutanten des Virus der infektiösen Bursal-Krankheit
DK1610817T3 (da) Infektiøs bronkitis virus med et ændret spike-gen
MXPA03009763A (es) Vacuna contra el virus de la enfermedad de la fiebre aftosa.
TW200617166A (en) Multivalent avian influenza vaccines
ECSP14023407A (es) Virus de la enfermedad de marek modificado y vacunas elaboradas con él
ES2053477T3 (es) Vacuna viva para enfermedades contagiosas de pollos.
BRPI0414073A (pt) método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
TW200710224A (en) Attenuated avian infectious bronchitis virus vaccines
DK1132466T3 (da) Kyllingeanæmivira med lav patogenicitet
RU2019135237A (ru) Штамм РВ-07 вируса инфекционного бронхита кур семейства Coronaviridae
DE602005012252D1 (de) Vakzine-zusammensetzungen aus streptomyces

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties